Navigation Links
Navigating the IP Minefield of Human Embryonic Stem Cell Development
Date:5/8/2012

FARMINGTON, Conn., May 8, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new reports

Opportunities in Human Embryonic Stem Cell (hESC) Products
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, the stage reached 4 to 5 days after fertilization. They are the most pluripotent of all stem cell types, able to develop into any of over 200 different cell types in the human body, rending them tremendously useful for their therapeutic potential. However, human embryonic stem cell research is heavily encumbered by patents held by the University of Wisconsin's Wisconsin Alumni Research Foundation (WARF), which creates significant challenges for guidance for companies seeking to develop new products.

BioInformant's new Opportunities in Human Embryonic Stem Cell (hESC) Products market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market. Over the past 15 years, WARF has been the major "gatekeeper" in determining which research product companies are able to conduct research, create commercial products, and develop novel therapies using hESCs. To date, WARF has entered into licensing agreements with only 27 commercial partners for its intellectual portfolio related to isolating and differentiating hESCs.

While Invitrogen, Becton Dickinson and Chemicon have disclosed licensing agreements with WARF, many research products companies have be forced to explore less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species. This report will give readers a fuller, more complete understanding of the complex IP situation in the hESC market, before they make any costly development decisions.

An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/biof239705-opportunities-human-embryonic-stem-cell-hesc.html

Capitalizing on Opportunities in Cord Blood Industry Growth
For even greater depth, companies involved in regenerative medicine research and development can turn to BioInformant's Cord Blood Industry Opportunities report to help guide future research and product design to ensure strong future sales and growth.

BioInformant's new market report "Capitalizing on Cord Blood Industry Growth" is particularly useful because it provides a direct link into the minds of a large, global population of parents, offering findings that have not been made available previously. This report also offers the most complete overview available anywhere of active global cord blood banks, tracking all 521 specific Cord Blood Banks operating in the world today.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof234290-capitalizing-on-opportunities-cord-blood-industry.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Navigating in the ocean of molecules
2. Swiss Institute of Bioinformatics celebrates 10th birthday by presenting major gifts to human health
3. Scientists identify novel inhibitor of human microRNA
4. During exercise, the human brain shifts into high gear on alternative energy
5. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
6. Research shows Brazilian acai berry antioxidants absorbed by human body
7. Study: Bird diversity lessens human exposure to West Nile Virus
8. Human Microbiome Project awards funds for technology development, data analysis and ethical research
9. TheVisualMD.com launches new animated 3-D views of human body in action
10. Gene with probable role in human susceptibility to pulmonary tuberculosis identified
11. The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, ... global financial services provider, today announced an agreement with NuData ... biometrics, to join forces. The partnership will enable clients to ... in compliance with local data protection regulation. ... In order to provide ...
(Date:12/15/2016)... AUBURN HILLS, Mich. , Dec. 15, 2016 /PRNewswire/ ... simply unlocking car doors or starting the engine. Continental ... 2017 in Las Vegas . Through ... PASE (Passive Start and Entry) and biometric elements, the ... the field of vehicle personalization and authentication. ...
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... N.Y. , Jan. 18, 2017 Acupath ... services, announces the formation of an Executive Committee that ... and beyond. John Cucci , a ... promoted from Director of Business Development to Chief ... 2015, Mr. Cucci served in senior sales leadership roles ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB ... V E FPGA into a compact business-card sized form factor suitable for prototyping, ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, will feature data ... napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held ... . Napabucasin is an orally-administered investigational ... STAT3. i Cancer stem cells (CSCs) possess the ...
Breaking Biology Technology: